Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Mark,Ballow ^[1] ; Raúl,Ortiz-de-Lejarazu ^[2] ; Isabella,Quinti ^[3] ; Matthew S,Miller ^[4] ; Klaus,Warnatz ^[5]

作者单位： Division of Allergy & Immunology, Morsani College of Medicine, University of South Florida, at Johns Hopkins All Children's Hospital, St. Petersburg Florida, FL, United States. ^[1] Professor of Microbiology, Scientific Advisor & Emeritus Director, National Influenza Center, Valladolid, Spain. ^[2] Department of Molecular Medicine, Sapienza University of Rome, Head of the Primary Immunodeficiency Unit, Rome, Italy. ^[3] Michael G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada. ^[4] Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Freiburg, Germany.;Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Freiburg, Germany.;Department of Clinical Immunology, University Hospital Zurich, Zurich, Switzerland. ^[5]

关键词 immunoglobulin replacement therapy influenza primary immunodeficiency secondary immunodeficiency vaccination